Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.691,58
-0,05%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cue Biopharma Inc (CUE) Cue Biopharma Inc (CUE) Notizie

CUE

Cue Biopharma (CUE)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CUE
DataOraFonteTitoloSimboloCompagnia
24/05/202422:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CUECue Biopharma Inc
09/05/202422:05GlobeNewswire Inc.Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
09/05/202422:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
09/05/202422:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CUECue Biopharma Inc
08/05/202414:00GlobeNewswire Inc.Cue Biopharma to Present at the 20th Annual PEGS Boston SummitNASDAQ:CUECue Biopharma Inc
07/05/202414:00GlobeNewswire Inc.Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences ConferenceNASDAQ:CUECue Biopharma Inc
24/04/202416:01GlobeNewswire Inc.Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CUECue Biopharma Inc
08/04/202422:05GlobeNewswire Inc.Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business HighlightsNASDAQ:CUECue Biopharma Inc
02/04/202414:00GlobeNewswire Inc.Cue Biopharma to Host Business Update Call and WebcastNASDAQ:CUECue Biopharma Inc
08/03/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
29/02/202416:00GlobeNewswire Inc.Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers SymposiumNASDAQ:CUECue Biopharma Inc
06/02/202414:00GlobeNewswire Inc.Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:CUECue Biopharma Inc
22/11/202314:00GlobeNewswire Inc.Cue Biopharma to Present at the JMP Securities Hematology and Oncology SummitNASDAQ:CUECue Biopharma Inc
09/11/202322:05GlobeNewswire Inc.Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
07/11/202314:00GlobeNewswire Inc.Cue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in NovemberNASDAQ:CUECue Biopharma Inc
03/11/202317:00GlobeNewswire Inc.Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms’ Tumor 1 Positive Cancers at SITC 2023NASDAQ:CUECue Biopharma Inc
27/09/202315:05GlobeNewswire Inc.Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual MeetingNASDAQ:CUECue Biopharma Inc
26/09/202314:00GlobeNewswire Inc.Cue Biopharma Announces Completion of Patient Enrollment in Phase 1b Study of CUE-101 in Combination with KEYTRUDA®NASDAQ:CUECue Biopharma Inc
09/08/202322:10GlobeNewswire Inc.Cue Biopharma Reports Second Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
14/06/202314:00GlobeNewswire Inc.Cue Biopharma to Present at the Federation of Clinical Immunology Societies (FOCIS) 2023 Annual MeetingNASDAQ:CUECue Biopharma Inc
09/06/202322:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CUECue Biopharma Inc
07/06/202314:00GlobeNewswire Inc.Cue Biopharma to Host Investor CallNASDAQ:CUECue Biopharma Inc
05/06/202314:00GlobeNewswire Inc.Cue Biopharma to Present at the Jefferies 2023 Global Healthcare ConferenceNASDAQ:CUECue Biopharma Inc
30/05/202312:06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CUECue Biopharma Inc
25/05/202323:00GlobeNewswire Inc.Cue Biopharma Presents Positive Data Update from Ongoing Phase 1 Trials of CUE-101 for Recurrent/Metastatic HPV+ Head and Neck Squamous Cell Carcinoma at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CUECue Biopharma Inc
15/05/202314:00GlobeNewswire Inc.Cue Biopharma to Present at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CUECue Biopharma Inc
09/05/202322:35GlobeNewswire Inc.Cue Biopharma Reports First Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
09/05/202322:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CUECue Biopharma Inc
08/05/202314:00GlobeNewswire Inc.Cue Biopharma to Present at the Upcoming JMP Securities Life Sciences ConferenceNASDAQ:CUECue Biopharma Inc
28/04/202322:18Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CUECue Biopharma Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CUE

La tua Cronologia

BIT
P20CV3
NLBNPIT20CV3 20240621 34...
BIT
P21NP0
NLBNPIT21NP0 20991231 11...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network